Brand Profile · Modern Cannabinoid Apothecary & Wellness
Madge and Mercer Modern Apothecary formulates research-backed cannabinoid wellness remedies, skincare serums, and micro-dosed vapes out of Toronto, Ontario. Operating through federal corporation 11824147 Canada Inc. via licensed processing partnerships, founder and CEO Shauna Levy launched the female-led brand in 2020 to address midlife physiological health, perimenopause, and chronic discomfort. Centered on flagship formulations MM 001 La Calma sublingual oil, MM 004 L’Émollient facial serum, and MM 005 Bonne Nuit CBN vaporizers, the modern apothecary distributes nationwide through the Ontario Cannabis Store, provincial wholesale boards, authorized dispensaries, and Herbal Dispatch medical channels.
| Legal corporate entity | 11824147 Canada Inc., operating as Madge and Mercer Modern Apothecary |
|---|---|
| Regulatory structure | Asset-light brand house formulating under Health Canada Licensed Producer processing agreements |
| Commercial debut | August 2021 (Founded in 2020 by Shauna Levy) |
| Headquarters | Toronto, Ontario, Canada |
| Founder & leadership | Shauna A. Levy (Founder & CEO), Kathryn From (Board Director) |
| Core demographic focus | Midlife women, perimenopausal and menopausal symptom support, chronic pain, and sleep fragmentation |
| Formulation philosophy | Whole-plant full/broad-spectrum extracts, non-intoxicating micro-dosing, and botanical terpene flavor masking |
| Flagship formulations | MM 001 La Calma Oil, MM 002 El Alevio Menta Vape, MM 004 L’Émollient Facial Serum, MM 005 Bonne Nuit CBN Vape |
| Distribution channels | Ontario Cannabis Store (OCS), AGLC, BCLDB, Herbal Dispatch, IPS Pharma (UK medical export), and private dispensaries |
| On Legacies | Legacies Feature: Design, Apothecary Science, and Midlife Wellness with Shauna Levy |
Madge and Mercer emerged from founder Shauna Levy’s personal quest to reclaim her vitality after a seven-year struggle with chronic pain and debilitating anxiety.
Conventional pharmaceuticals left Levy cognitively impaired and fatigued. Guided by a cannabinoid clinician, she discovered that daily high-dose CBD paired with micro-dosed THC provided profound physical relief without psychoactive intoxication, allowing her to resume an active executive career.
Drawing on twenty-five years leading Canadian cultural institutions—co-founding the Interior Design Show and directing Toronto’s Design Exchange museum—Levy recognized a systemic void in Canada’s legal market. Emerging dispensaries targeted young male consumers with high-THC combustibles, ignoring mature women navigating perimenopause, joint inflammation, and sleep disruption. In 2020, Levy founded Madge and Mercer under 11824147 Canada Inc. to modernize botanical self-care.
To sidestep the capital-intensive burdens of facility construction, Levy established an asset-light corporate model, maintaining strict internal control over formulations and industrial design while partnering with Health Canada licensed processors. Commercially debuting in August 2021, the apothecary introduced high-CBD sublingual oils, micro-dose vapes, and whole-plant facial serums packaged in clinical, UV-protective glass, proving that sophisticated design and rigorous chemistry can destigmatize cannabis.
Milestones
Shauna Levy incorporates 11824147 Canada Inc. in Toronto, securing early female-led investment to create Madge and Mercer Modern Apothecary.
The brand commercially debuts in Ontario through the Ontario Cannabis Store (OCS) with MM 001 La Calma and MM 002 El Alevio Menta.
Bay Street Bull designates Shauna Levy a Woman of the Year for pioneering research-backed cannabis wellness.
Madge and Mercer introduces MM 004 L’Émollient, formulating one of Canada’s first true whole-plant cannabis facial serums with meadowfoam seed oil.
The company expands distribution westward into Alberta and British Columbia, while launching international medical exports to the United Kingdom via IPS Pharma.
Madge and Mercer expands its cannabinoid portfolio with MM 005 Bonne Nuit CBN vape, while hosting Madge Love Talks educational forums on women’s midlife health.
Madge and Mercer approaches cannabinoid product development through pharmaceutical-grade botanical compounding.
The team rejects isolated synthetic CBD crystals from industrial hemp, choosing full-spectrum and broad-spectrum extracts from whole cannabis plants. This architecture harnesses the biological entourage effect, combining high concentrations of CBD with sub-psychoactive micro-doses of THC, secondary cannabinoids like CBG and CBN, and synergistic plant terpenes.
Sensory de-escalation guides every formula. Recognizing that harsh, skunky cannabis odors deter new consumers, Levy infuses functional botanical excipients that neutralize cannabis aromas while delivering therapeutic benefits. Formulas feature cold-pressed orange peel, fresh field mint, lemongrass, and ginger. In topical applications, carrier lipids like meadowfoam seed oil and plant squalane enhance dermal bioavailability, delivering active cannabinoids directly to cutaneous receptors.
| Corporate designation | 11824147 Canada Inc. (d.b.a. Madge and Mercer) |
|---|---|
| Manufacturing model | Asset-light formulation developer partnered with Health Canada Licensed Processors |
| Active cannabinoid spectrum | Whole-plant full-spectrum and broad-spectrum extracts (high CBD, micro-dose THC, CBN, CBG) |
| Botanical excipients | Meadowfoam seed oil, plant-derived squalane, lemongrass, ginger, cold-pressed orange peel |
| Aroma management | 100% natural steam-distilled essential oils and botanical terpenes neutralizing raw skunky notes |
| Delivery mechanisms | Sublingual lipid tinctures (MCT base), transdermal dermal serums, and all-in-one inhalation units |
| Packaging materials | UV-protective apothecary glass droppers, clinical airless containers, discreet ceramic hardware |
| International compliance | Export-grade manufacturing meeting UK Schedule II unlicensed medicines standards via IPS Pharma |
Health Canada licensed processors extract broad-spectrum and full-spectrum cannabinoid fractions preserving native terpenes.
Technicians blend calibrated 25:1 and 20:1 CBD:THC ratios, guaranteeing predictable, non-intoxicating therapeutic outcomes.
Compounding chemists blend therapeutic carriers—including organic meadowfoam oil, squalane, lemongrass, and ginger extracts.
Formulations enter UV-protective glass apothecary bottles and precision inhalation hardware under strict analytical testing.
Intentionally calibrated cannabinoid ratios paired with functional botanical excipients for restorative daily wellness.
Whole-Plant Cannabis Facial Serum (25 mL)
Sublingual Ingestible Tincture (25 mL)
Apothecart 510-Thread Cartridge (1.0 g)
Analytical guarantee: Every Madge and Mercer lot undergoes full-panel third-party laboratory testing verifying cannabinoid potency, pesticide absence, and heavy metal compliance.
Madge and Mercer bridges provincial adult-use boards, authorized medical channels, and international pharmaceutical export corridors.
Provincial wholesale boards
Government supply boards direct Madge and Mercer tinctures, topicals, and vapes to licensed private dispensaries across Ontario, Alberta, and British Columbia.
Medical cannabis platform
Authorized medical platform delivering Madge and Mercer wellness remedies directly to registered Canadian patients requiring non-intoxicating symptom management.
Contract manufacturing partners
Federal licensed processing facilities execute commercial extraction, lipid compounding, analytical testing, and federal excise stamping under quality service contracts.
International pharmaceutical export
Specialized distributor supplying MM 002 El Alevio Menta inhalation pens to licensed medical prescribers across the UK under the unlicensed medicines framework.
Madge and Mercer earned enthusiastic acclaim for legitimizing cannabis within midlife women’s self-care, navigating third-party production dependencies and strict promotional constraints.
Madge and Mercer demonstrates how thoughtful industrial design and precision pharmacology redefine cannabis for mature consumers. By addressing perimenopause, chronic inflammation, and sleep fragmentation through whole-plant micro-dosing and elegant presentation, Shauna Levy establishes an enduring category that bridges modern medicine with everyday luxury self-care.
Founder and CEO Shauna Levy discusses transitioning from cultural institution leadership to cannabis entrepreneurship, navigating asset-light manufacturing, and formulating cannabinoid solutions for women.
Terms used on this page
Entrepreneur and design leader Shauna A. Levy founded Madge and Mercer Modern Apothecary in 2020 under corporate entity 11824147 Canada Inc., directing product research, chemical ratios, and brand architecture from Toronto, Ontario.
Shauna Levy created the brand following a personal seven-year battle with debilitating chronic pain and anxiety at age 46, discovering that daily high-dose CBD paired with micro-dosed THC provided relief without the cognitive impairments of pharmaceuticals.
Madge and Mercer operates an asset-light corporate structure, managing internal formulation development and design while partnering with Health Canada Licensed Producers to handle active extraction, analytical testing, packaging, and provincial supply.
Unlike mainstream cosmetic products made with cannabinoid-free hemp seed oil, MM 004 L’Émollient infuses genuine whole-plant active cannabis resin (350 mg CBD and 17.5 mg THC) into an organic meadowfoam seed oil and squalane base.
Yes, Madge and Mercer purposefully engineers cannabinoid and botanical formulations to support women experiencing midlife physiological changes, including joint inflammation, hormonal fluctuations, sleep latency, and anxiety.
Yes, Madge and Mercer introduced its MM 002 El Alevio Menta inhalation unit into the United Kingdom through pharmaceutical distributor IPS Pharma, supplying authorized medical prescribers under the UK’s unlicensed medicines framework.
Canadian consumers can purchase Madge and Mercer formulations through the Ontario Cannabis Store (OCS), provincial retail dispensaries across Ontario, Alberta, and British Columbia, and online through Herbal Dispatch for registered medical patients.
Brand profile compiled by Legacies Podcast · Last reviewed October 2026
Guests who have represented or discussed Velocity Motors
Our newsletter is packed with insights, inspiration, and expert advice, it’s the ultimate tool for leveling up your life. Don’t miss out – sign up today!
By clicking Sign Up you’re confirming that you agree with our Terms and Conditions.
